Literature DB >> 27964798

Immunization in patients with inflammatory rheumatic diseases.

Konstantinos Thomas1, Dimitrios Vassilopoulos2.   

Abstract

Immunization represents the most efficient and simplest intervention to prevent certain viral and bacterial infections in the general population as well as in the vulnerable population of patients with inflammatory rheumatic diseases treated with immunosuppressives. Here, we present an updated review of literature data regarding the safety and efficacy of immunizations against different pathogens in rheumatic patients treated with conventional immunosuppressives or the newer biologic agents while at the same time we provide practical guidance for the appropriate vaccine administration in this patient population.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biologics; Corticosteroids; Disease modifying anti-rheumatic drugs; Hepatitis B virus; Herpes zoster; Human papilloma virus; Influenza; Pneumococcal; Vaccines

Mesh：

Substances：

Year:  2016        PMID： 27964798     DOI： 10.1016/j.berh.2016.10.009

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN： 1521-6942            Impact factor:   4.098


  6 in total

1.  Clinical characteristics and prognosis of community-acquired pneumonia in autoimmune disease-induced immunocompromised host: A retrospective observational study.

Authors:  Zhong-Shu Kuang; Yi-Lin Yang; Wei Wei; Jian-Li Wang; Xiang-Yu Long; Ke-Yong Li; Chao-Yang Tong; Zhan Sun; Zhen-Ju Song
Journal:  World J Emerg Med       Date:  2020

Review 2.  Comorbidity burden in systemic sclerosis: beyond disease-specific complications.

Authors:  Eleni Pagkopoulou; Alexandra Arvanitaki; Dimitrios Daoussis; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2019-07-12       Impact factor: 2.631

Review 3.  Recommendations and barriers to vaccination in systemic lupus erythematosus.

Authors:  Megha Garg; Naaima Mufti; Tara N Palmore; Sarfaraz A Hasni
Journal:  Autoimmun Rev       Date:  2018-08-11       Impact factor: 9.754

4.  Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study.

Authors:  George E Fragoulis; Ioannis Grigoropoulos; Evgenia Mavrea; Aikaterini Arida; Vassiliki-Kalliopi Bournia; Gerasimos Evangelatos; Kalliopi Fragiadaki; Anastasios Karamanakos; Evrydiki Kravvariti; Stylianos Panopoulos; Maria Pappa; Konstantinos Thomas; Maria G Tektonidou; Dimitrios Paraskevis; Dimitrios Vassilopoulos; Petros P Sfikakis
Journal:  Rheumatol Int       Date:  2021-03-04       Impact factor: 2.631

5.  Multicenter Cross-sectional Study of Patients with Rheumatoid Arthritis in Greece: Results from a cohort of 2.491 patients.

Authors:  Konstantinos Thomas; Argiro Lazarini; Evripidis Kaltsonoudis; Alexandros Drosos; Ioannis Papalopoulos; Prodromos Sidiropoulos; Pelagia Katsimbri; Dimitrios Boumpas; Panagiota Tsatsani; Sousana Gazi; Kalliopi Fragkiadaki; Maria Tektonidou; Petros P Sfikakis; Lina Pantazi; Kyriaki A Boki; Eleftheria P Grika; Panagiotis G Vlachoyiannopoulos; Konstantina Karagianni; Lazaros I Sakkas; Theodoros Dimitroulas; Alexandros Garyfallos; Dimitrios Kassimos; Gerasimos Evangelatos; Alexios Iliopoulos; Maria Areti; Constantinos Georganas; Konstantinos Melissaropoulos; Panagiotis Georgiou; Periklis Vounotrypidis; Konstantinos Ntelis; Clio P Mavragani; Ilias Bournazos; Gikas Katsifis; Christos Mavrommatis; George D Kitas; Dimitrios Vassilopoulos
Journal:  Mediterr J Rheumatol       Date:  2018-03-19

Review 6.  Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations.

Authors:  Christos Koutsianas; Konstantinos Thomas; Dimitrios Vassilopoulos
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-03-16       Impact factor: 5.346
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.